Results 231 to 240 of about 53,193 (289)

Salivary gland secretory carcinoma with an ETV6::RET fusion: A case report. [PDF]

Biomed Rep
Ishihara A, Kuwabara H, Yasuda E, Jinnin T, Higashino M, Nagao T, Haginomori SI, Hirose Y.   +7 more
europepmc   +1 more source

RET/TRIM33 Fusion Gene [PDF]

, 2020
openaire   +1 more source

The spectrum of breast in situ papillary carcinomas with invasion and invasive breast carcinomas with papillary features: an overview of histological subtypes and diagnostic challenges

Histopathology, Volume 88, Issue 4, Page 747-768, March 2026.
Invasive breast carcinomas with papillary features (IBCP) comprise diverse subtypes with variable architecture, histopathology, and clinical behaviour. This review outlines evolving classification, diagnostic criteria, and treatment implications, highlighting challenges in distinguishing in situ from invasive lesions. Standardised diagnostic approaches
Emad A Rakha, Puay Hoon Tan, Wendy A Raymond   +2 more
wiley   +1 more source

Preoperative selpercatinib induces major pathological response in a patient with stage IIIA, RET fusion-positive non-small cell lung cancer: A case report. [PDF]

Medicine (Baltimore)
Breitenecker K, Fabikan H, Weinlinger C, Krenbek D, Klikovits T, Watzka S, Valipour A, Hochmair MJ.   +7 more
europepmc   +1 more source

Case report: Intrapleural plus systemic Tislelizumab injection combined chemotherapy in RET gene fusion-positive lung adenocarcinoma presenting refractory malignant pleural effusion [PDF]

Dong Qiu, Xiaohui Zhang, Yang Wang, Cheng Chen   +3 more
openalex   +1 more source

Dermatologic Features of Endocrine Tumor Syndromes—Systematic Review and Meta‐Analysis

International Journal of Dermatology, Volume 65, Issue 3, Page 464-488, March 2026.
ABSTRACT Endocrine tumor syndromes, including multiple endocrine neoplasia types 1, 2A, and 2B (MEN1, MEN2A, MEN2B), Carney complex (CNC), and PTEN hamartoma tumor syndrome (PHTS), are hereditary conditions characterized by multisystem tumor development.
Sára Pálla, Zseraldin Metyovinyi, Fanni Adél Meznerics, Arash Mirzahosseini, Judit Tőke, Miklós Tóth, Henriett Butz, Attila Patócs, Márta Medvecz   +8 more
wiley   +1 more source

23P Clinical impact and prognostic value of EGFR mutation co-occurring with ALK, ROS1, RET fusions, or MET exon 14 skipping mutations in Chinese patients with non-small cell lung cancer [PDF]

Lin Shen, K. Liu, Siyu Li
openalex   +1 more source

Gene therapy for epilepsy: An emerging, promising approach for a serious neurological disorder

Journal of Internal Medicine, Volume 299, Issue 3, Page 302-327, March 2026.
Abstract Gene therapy is emerging as a groundbreaking strategy for treating epilepsy, offering new hope to patients who do not respond to conventional medications. Despite advancements in anti‐seizure treatments, nearly 30%–40% of individuals with epilepsy continue to experience uncontrolled seizures, highlighting the urgent need for more effective and
Marco Ledri, Merab Kokaia
wiley   +1 more source

Successful surgical management of a patient with osteoradionecrosis of the jaw with RET fusion-positive advanced thyroid cancer: A case report. [PDF]

Exp Ther Med
Kimura T, Sakata KI, Yoshikawa K, Munekata T, Itagaki T, Maeda T, Kanayama J, Sato J, Yanagawa Matsuda A, Kitagawa Y.   +9 more
europepmc   +1 more source

36P Selpercatinib treatment beyond progression (PD) in RET fusion-positive NSCLC: Association with pattern of PD [PDF]

Maria J. de Miguel, Benjamin Besse, Yoon Jun Kim, Melissa L. Johnson, June M. Chan, Patrick Peterson, Sylwia Szymczak, Tarun Puri, Daniel Shao-Weng Tan   +8 more
openalex   +1 more source